Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adoptive TIL therapy plus nivolumab for metastatic melanoma
NL-OMON45469Withdrawn
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of nivolumab, sponsored by Leiden University Medical Center. Planned start Mar 2017; status: withdrawn.
02
Drugs
Beyond the preview
Go deeper on NL-OMON45469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45469.